RRT Stockpile Call Off Terms - Fresenius
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 +1 more |
| Region | London |
| Procedure | limited |
| OCID | ocds-h6vhtk-028dc8 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Fresenius Medical Care (UK) Limited | · | · | active |
description
The Department of Health and Social Care (DHSC) has procured a range of Continuous Renal Replacement Therapies (CRRT) Consumables and Equipment, which will be stored as a Stockpile by the Supplier. It is intended for the Products to be distributed for patients solely in the UK during a pandemic or other period of increased demand and / or potential shortage in the UK and for this purpose the Stockpiled Products must be stored in the UK. In the event of a shortage in the UK, the Authority can direct the Supplier to buy back all or some of the stock they hold, and release it through the normal UK supply chain. In the period leading up to expiry of the Agreement, the Supplier will be required, through an agreed Exit Plan, to buy back the stock. The Agreement is for twelve (12) months with the option to extend the contract for a further period of up to twelve (12) months subject to the written agreement of both parties.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 27 Jan 2021 | Contract award notice (F03) | Earlier regulations | 001650-2021 |
| 9 Jul 2021 | Corrigendum (F14) | Earlier regulations | 016050-2021 |
| 9 Jul 2021 | Corrigendum (F14) | Earlier regulations | 016047-2021 |
more from Department of Health and Social Care
- DHSC: Fin: Interim Senior Financial Accountant · £94,250 · 29 Jul 2026
- DHSC: Fin: Interim Financial Accountant · £66,400 · 29 Jul 2026
- DHSC Sinogo claim legal support · £100,000 · 22 Jul 2026
- National Institute for Health and Care Research (NIHR) pre-action letter advice · £80,000 · 22 Jul 2026
- DHSC: ASC: Waves 3 – 5 of the Adult Social Care Workforce Employee Survey · 15 Jul 2026
- Hugh's Report - MH Impact of Life-Threatening Child Illness on Families 2026 · 26 Jun 2026
- Library Mgmt and Enquiry System, E-Archive · £22,578 · 22 Jun 2026
- DHSC: Leeds Maternity Review legal services · £432,000 · 22 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.